Calyx's India IPO a beacon of hope for the CRAMS story?
This article was originally published in Scrip
Executive Summary
Can Calyx Chemicals and Pharmaceuticals' proposed initial public offering, potentially the first from an Indian pharmaceutical firm in 2013, be viewed as a harbinger of the reviving fortunes of the CRAMS segment or would investors tread cautiously?